v3.25.4
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 13, 2025
Nov. 11, 2025
Feb. 13, 2025
Feb. 07, 2025
Jan. 22, 2025
Oct. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2024
Sep. 30, 2025
Feb. 17, 2025
Dec. 30, 2024
Oct. 02, 2024
Sep. 27, 2024
Total face value     $ 31,250   $ 31,250       $ 279,878 $ 9,687,500   $ 40,625 $ 62,500 $ 1,066,391
Original issuance discounts     $ 6,250   6,250       46,646 $ 5,943,425   8,125 12,500 213,278
Number of shares issued, value             $ 28,561 $ 229,084            
Common Stock [Member]                            
Number of shares issued             2,238 17,950            
Number of shares issued, value             $ 2            
Purchase Agreement [Member] | Arena Business Solutions Global SPC II Ltd [Member]                            
Number of shares issued     100,000,000                      
Securities Purchase Agreement [Member] | Cobra Alternative Capital Strategies LLC [Member]                            
Derivative, Notional Amount                     $ 3,750,000      
Derivative, Average Variable Interest Rate                     92.50%      
Derivative, Floor Interest Rate                     4.00%      
Aspire Biopharma Inc [Member]                            
Total face value                 279,878     40,625 62,500 1,066,391
Original issuance discounts                 46,646     $ 8,125 $ 12,500 $ 213,278
Number of shares issued, value                          
Aspire Biopharma Inc [Member] | Common Stock [Member]                            
Number of shares issued                          
Number of shares issued, value                          
Subsequent Event [Member] | Common Stock [Member]                            
Debt conversion, converted instrument, shares issued 48,050,971         9,900,237                
Subsequent Event [Member] | Convertible Debt [Member]                            
Conversion of convertible notes into common stock $ 5,260,571         $ 1,631,661                
Subsequent Event [Member] | E L O C Agreement [Member]                            
Number of shares issued   100,000,000                        
Number of shares issued, value   $ 250,000                        
Share fee   $ 25,000                        
Subsequent Event [Member] | Aspire Biopharma Inc [Member]                            
Stockholders equity reverse stock split       Company’s board of directors voted unanimously to a 15.9538267 for 1 reverse split                    
Business combination of outstanding common shares       531,822,059                    
Subsequent Event [Member] | Aspire Biopharma Inc [Member] | Purchase Agreement [Member] | Arena Business Solutions Global SPC II Ltd [Member]                            
Number of shares issued     100,000,000                      
Subsequent Event [Member] | Aspire Biopharma Inc [Member] | Securities Purchase Agreement [Member] | Cobra Alternative Capital Strategies LLC [Member]                            
Derivative, Notional Amount                     $ 3,750,000      
Derivative, Average Variable Interest Rate                     92.50%      
Derivative, Floor Interest Rate                     4.00%      
Subsequent Event [Member] | Non Convertible 20 % OlD Note Payable [Member] | Aspire Biopharma Inc [Member]                            
Total face value         31,250                  
Gross proceeds         $ 2,500,000                  
Exit fee percentage         5.00%                  
Original issuance discounts         $ 6,250